HOME >> BIOLOGY >> NEWS
J&JPRD discovery may lead to new treatments for chronic sensitivity, pain caused by cold

Raritan, NJ (May 2, 2007) -- Researchers at Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) today announced that they have discovered a biological basis for explaining how people sense cold temperatures.

Ultimately, these findings may be a critical step in developing treatments for patients who suffer from hypersensitivity to cold, such as occurs in neuropathic pain and complex regional pain syndromes. This research is published in the May 3, 2007 issue of Neuron.

In the study, researchers sought to understand the mechanisms underlying cold sensitivity. Scientists used a line of mice that lacked a critical ion channel receptor called TRPM8, also referred to as the cold menthol receptor 1. Then, they tested how these mice reacted to cold stimuli, and found that not having these receptors reduced their adverse reactions to the cold, both under normal and pathological conditions. Results suggest that TRPM8 modulation could play an important role in certain types of cold-induced pain in humans and could hold therapeutic potential in the treatment of many chronic, painful conditions for which there are currently limited effective treatment options.

"This work represents the culmination of a multi-year collaborative effort on the part of J&JPRD scientists to help explain fundamental mechanisms involved in human pain states and may lead to the development of innovative medicines to relieve patient suffering," said Christopher Flores, Ph.D., Biology Team Leader for Analgesics, J&JPRD. "Although preliminary, these findings provide compelling initial evidence toward validating TRPM8 as an analgesic drug target and addressing major unmet medical needs of pain patients."

Ion channels are proteins that form tiny openings through the membrane of a cell and allow the passage of certain ions that regulate cellular activities. Some of these channels are opened by chemicals, some by changes in voltage and othe
'"/>

Contact: Lisa Vaga
lvaga@prdus.jnj.com
908-218-7316
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
2-May-2007


Page: 1 2

Related biology news :

1. Enzyme discovery sheds light on vitamin D
2. New proteomics research promises to revolutionize biomedical discovery
3. MU researchers make discovery in molecular mechanics of phototropism
4. International team to honor 30th anniversary of deep-sea vent discovery in Galpagos
5. Screening approach leads to discovery of gene linked to breast cancer
6. Lucky 13 as new gene discovery offers further hope for childhood blindness
7. Plants that produce more vitamin C may result from UCLA-Dartmouth discovery
8. Biting discovery: MU entomologist finds host of new aquatic insect species in Thailand
9. Protein enables discovery of quantum effect in photosynthesis
10. Unicellular microRNA discovery
11. Jefferson researchers discovery may change thinking on how viruses invade the brain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... ... 2020 , ... Shoreline Biome , a microbiome research company that develops ... company will debut a novel new DNA isolation kit at the Miami Winter ... Rapid Prep kit, is a fast and easy-to-use kit designed for the efficient and ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... new public-private Manufacturing USA initiative, the Advanced Regenerative Manufacturing Institute (ARMI). Headquartered ... brings together a consortium of over 100 partner organizations from industry, government, ...
(Date:1/8/2020)... ... January 08, 2020 , ... R3 Stem Cell, ... to its nationwide practice network partners. Not only does this save practices ... its Network the biologics themselves are less expensive. , Since the regenerative biologics ...
Breaking Biology News(10 mins):
(Date:1/28/2020)... , ... January 28, 2020 , ... ... Better Salivary Assay Kits . The new Salivary Total Human IgG Assay ... measuring total immunoglobulin G in saliva, researchers can extend the accuracy and ease ...
(Date:1/27/2020)... ... January 27, 2020 , ... Valencell, the leading innovator ... investors led by Halma plc , a FTSE 100 global group of ... LLC, and WSJ Joshua Fund. A representative from Halma will join the Valencell ...
(Date:1/24/2020)... RIDING, Va. (PRWEB) , ... January 24, 2020 ... ... and other innovations created by companies in biotechnology, diagnostics, therapeutics, laboratory and clinical ... lives of millions of people around the world. And as Slone Partners ...
(Date:1/23/2020)... ... January 22, 2020 , ... Ideal Implant CEO and ... at two recent North American investor forums specializing in medical advancements. New technology ... & Diagnostics Forum on November 21, 2019 in New York City, and the ...
Breaking Biology Technology:
Cached News: